Segun Majekodunmi
with agency reports
The National Food Drug Administration Control Agency (NAFDAC) and other key regulatory agencies, have disclosed that they are poised to take sterner measures to curb the influx of fake contaminated drugs and imported foodstuffs into the country.
Over the years, the regulatory agencies have been on top of their watch to tackle the tendencies that could make Nigeria a 'dumping zone' for expired drugs in which malaria drugs are not left out.
Living with malaria in Nigeria has been a serious life-threatening disease which is caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites its victim, the parasite gets released into the human bloodstream.
Once the human body becomes host for the parasite, it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC).
Humans suffering from malaria frequently experience fever, headache, weakness, vomiting and general body pain
The improvements in technological advancements related to diagnostic tools with the growing demand for treatment in malaria-endemic countries is driving this market. Major factors driving the growth of the market away from the fake drugs culprit are increase in association between the industry and research centers.
In the current years, there has been a renewed interest and commitment by the WHO to eradicate malaria in Nigeria and other 34 countries by 2030.
WHO also estimated that as far back as 2016, there were 216 million clinical episodes and 445,000 deaths to malaria in developing countries.
The agencies agree that fake medicine is a major problem in Africa. Anyone using fake or expired malaria drugs makes their health conditions more worsen.
On high to identify fake drugs, they noted that their names are often spelt wrongly or the expiring date extended from two years which it is suppose to use in the market.
Weak regulatory framework and lack of awareness across the country has been a prime concern for the manufacturers and healthcare providers. Similarly, the absence of strong import and export guidelines can lead to the use of sub-standard products that can lead to additional complications for patients.
Besides, the long registration procedures, the market entry parameters must be assessed carefully for investment considerations.
However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market.
For a productive Nigerian economy with a population of over 100 million , the people must be healthy.
One way to attain this is to step up the efforts in curbing the influx of fake drugs and products into the country.
with agency reports
The National Food Drug Administration Control Agency (NAFDAC) and other key regulatory agencies, have disclosed that they are poised to take sterner measures to curb the influx of fake contaminated drugs and imported foodstuffs into the country.
Living with malaria in Nigeria has been a serious life-threatening disease which is caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites its victim, the parasite gets released into the human bloodstream.
Once the human body becomes host for the parasite, it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC).
Humans suffering from malaria frequently experience fever, headache, weakness, vomiting and general body pain
The improvements in technological advancements related to diagnostic tools with the growing demand for treatment in malaria-endemic countries is driving this market. Major factors driving the growth of the market away from the fake drugs culprit are increase in association between the industry and research centers.
In the current years, there has been a renewed interest and commitment by the WHO to eradicate malaria in Nigeria and other 34 countries by 2030.
WHO also estimated that as far back as 2016, there were 216 million clinical episodes and 445,000 deaths to malaria in developing countries.
The agencies agree that fake medicine is a major problem in Africa. Anyone using fake or expired malaria drugs makes their health conditions more worsen.
On high to identify fake drugs, they noted that their names are often spelt wrongly or the expiring date extended from two years which it is suppose to use in the market.
Weak regulatory framework and lack of awareness across the country has been a prime concern for the manufacturers and healthcare providers. Similarly, the absence of strong import and export guidelines can lead to the use of sub-standard products that can lead to additional complications for patients.
Besides, the long registration procedures, the market entry parameters must be assessed carefully for investment considerations.
However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market.
For a productive Nigerian economy with a population of over 100 million , the people must be healthy.
One way to attain this is to step up the efforts in curbing the influx of fake drugs and products into the country.
No comments:
Post a Comment